IIM
ORIC icon

INTECH Investment Management’s Oric Pharmaceuticals ORIC Stock Holding History

INTECH Investment Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$242K Sell
19,131
-7,475
-28% -$84.9K ﹤0.01% 1663
2025
Q4 		$218K Buy
26,606
+9,223
+53% +$106K ﹤0.01% 1936
2025
Q3 		$209K Sell
17,383
-8,064
-32% -$84.8K ﹤0.01% 2041
2025
Q2 		$258K Sell
25,447
-15,319
-38% -$103K ﹤0.01% 1959
2025
Q1 		$227K Buy
40,766
+12,053
+42% +$105K ﹤0.01% 2029
2024
Q4 		$232K Buy
28,713
+9,245
+47% +$84.8K ﹤0.01% 1967
2024
Q3 		$200K Buy
+19,468
New +$192K ﹤0.01% 1719

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

INTECH Investment Management's ORIC Position: Q1 2026 in Review

INTECH Investment Management reduced its Oric Pharmaceuticals (ORIC) stake by 28% in Q1 2026, selling an estimated $84.9K and leaving 19,131 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #1663.

INTECH Investment Management first reported a position in ORIC in Q3 2024 and has held it in 7 quarters since. The position peaked at $258K in Q2 2025. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • INTECH Investment Management held 19,131 shares of Oric Pharmaceuticals worth $242K as of Q1 2026.
  • INTECH Investment Management sold 7,475 Oric Pharmaceuticals shares in Q1 2026, an estimated $84.9K.
  • Oric Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1663 holding.
  • INTECH Investment Management first reported a position in Oric Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Oric Pharmaceuticals position peaked at $258K in Q2 2025.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.